CTTN and neoplasm: MiR‐542‐3p reduced cell viability, proliferation, tumor angiogenesis, invasion and metastasis, and induced apoptosis by targeting mRNAs, such as Survivin, FZD7, PIM1, cortactin, angiopoietin‐2, etc (Althoff et al., 2015; He et al., 2014; Long et al., 2016; Rang, Yang, Wang, & Cui, 2016; Wu et al., 2017).